We are international
Donate
• health professionals TEXT SIZE   
   back

KOS 2007: The Role of Thalidomide in Myeloma Patients Eligible for High-Dose Therapy
By Michele Cavo, MD
Michele Cavo, MD
Seràgnoli Institute of Hematology and Medical Oncology
Bologna UniversitySchool of Medicine
Italy
06.27.07

Be the first to comment

 related articles